Senior Medical Science Liaison, Rare Disease - Southern CA, NV, HI
Amgen
Summary
The Rare Disease Sr. Medical Science Liaison (MSL) acts as the primary scientific/clinical resource to Opinion Leaders (OLs), Population Health Decision Makers (PHDMs) and other health care providers and is responsible for executing Amgen Medical function and product strategy as led by MSL Leadership, with the goal of giving accurate information to OLs, community healthcare providers and PHDMs to improve patient outcomes. This is a field-based position within the U.S. Medical team reporting to the Director, West Medical Science Liaison Team, Severe Active GPA/MPA & Sjogren's Disease.
Job description
Accountabilities and Responsibilities
- Majority of time spent on peer-to-peer activities with Severe Active GPA/MPA and Sjogren's Opinion Leaders, community healthcare providers, and PHDMs to discuss and advance the scientific platform as aligned with Amgen's corporate goals and objectives.
- Engage with PHDMs within assigned IDNs and other institutions to communicate scientific based data of clinical value, outcomes, and economic data.
- Connect external and internal stakeholders to amplify Amgen's reach and access for patients.
- Conduct in-depth scientific exchange to provide focused and balanced clinical and scientific information consistent with MSL compliance standards.
- Support Amgen sponsored research and may serve as a study lead.
- Liaise with potential investigators in non-sponsored clinical research.
- Provide and/or present field observations and insights to internal stakeholders to inform Amgen strategies.
- Lead and support congress activities as aligned with strategy.
- Support speaker training as requested and ensure the speakers are updated on new data.
- Lead and/or participate on project teams that support MSL strategies and tactics as delegated by MSL leadership.
- Compliantly partner across all Amgen field roles who share customers to create an appropriately coordinated One Amgen experience.
- MSLs instill passion and move HCPs to take action in improving patient care related to closing care gaps.
- Mentor other MSLs as designated by MSL leadership.
- Execute all administrative responsibilities and training (e.g., Veeva CRM, expense reports, compliance modules, etc.) in a timely manner.
- Maintain and improve clinical/scientific acumen and expertise with current data/information and healthcare trends.
- Ability to build and maintain strong relationships with external stakeholders, and possess excellent communication skills to effectively communicate scientific data.
Requirements
- Doctorate degree OR Master's degree and 3 years of Medical Affairs experience OR Bachelor's degree and 5 years of Medical Affairs experience
- Pharm.D., Ph.D., M.D. or D.O. (other doctoral degrees considered) preferred
- Seven or more years in a medically related field, including 1 year focused on clinical practice, clinical research, or medical research preferred
- 2+ years in a medical science liaison role in a biotech or pharmaceutical company preferred
- Current experience in Scientific Affairs or Medical Affairs at a biotech or pharmaceutical company preferred
- Rare Disease-GPA/MPA and/or Sjogren's Disease expertise preferred
- Experience with designated territory preferred
Benefits
- Retirement and Savings Plan
- Medical, Dental & Vision
- Life and Disability Insurance
- Flexible Spending Accounts
- Discretionary Annual Bonus
- Stock-based Long-term Incentives
- Paid Time-off Plans
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.